InvestorsHub Logo
Followers 11
Posts 604
Boards Moderated 0
Alias Born 03/15/2010

Re: diarch post# 42430

Thursday, 03/23/2017 3:00:19 AM

Thursday, March 23, 2017 3:00:19 AM

Post# of 97093
I dare say evolution is primarily the gathering of temporal vs spatial knowledge. Look at business development ramps of bio or tech firms-typically lengthy and not without challenges and hurdles to overcome. You can't necessarily model the unexpected esp. when you challenge the norm. Success or failure is learned and then earned. DECN is a compelling risk-reward play. Empathize with all shareholders and fully expect a ROI on my holdings as well. However, critical mass is not dependent on it and that's why it's an OTC grandslam or strikeout play. My due diligence weights to the former for investors and patients. I get the SP playing, MB BS meter rhetoric as I'm sure many see thru it. It's old, stale and needs to be thrown out. NS keeps publishing rules on why messages are deleted-really? Some subjective analysis by some gatekeeper. It seems way too many are allowed that don't pass the sniff test. Oh well...looking for progress on the revenue side for Q1-2 and have patience to see it thru. Wind aided help may be on the way from Nevada as well...

Oh yeah, Go Blue. No Washington Generals to be found in the Sweet Sixteen.